CompaniesRenovacor

Renovacor

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

278

By Phase

NA: 2

By Status

TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Today
NCT01135303
NCT02357719
Hover over trial bars to see details

Recent Trials

NCT02357719Collaborator
Effectiveness of VistaO2 FLUX Device in Screening of Sleep Apnea/Hypopnea Syndrome
NATerminated
96 participants
Started: Mar 5, 2015 · Completed: Jun 2, 2017
NCT01135303Collaborator
Effectiveness of VistaO2 Device in Screening of Sleep Apnea/Hypopnea Syndrome
NACompleted
182 participants
Started: Feb 28, 2009 · Completed: Jan 31, 2011
Funding History (2)
D
Aug 4, 2021
Filing
D
Oct 15, 2019
Filing
Related Companies
Rocket Pharmaceuticals
acquired